Role of family history and genetic testing in diagnosis

First line treatment against metastatic breast cancer

Early phase 1/2 results with oral proteasome inhibitor MLN9708 in myeloma

Effects of panitumumab against oesophageal-gastro cancer and carcinomas

Effects of lapatinib and trastuzumab on progression free survival

Decision making in surgical breast cancer treatment

Hodgkin Lymphoma focusing on reducing radiotherapy, while maintaining the highest possible cure rate

Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies

ASCO 2012: Advances in myeloma

ASCO 2012: Advances in lymphoma; bendamustine combination in indolent lymphoma

President's overview of ASCO 2012

Drug shortage impact on cancer care and efforts to resolve the issue